Siderophore biosynthesis coordinately modulated the virulence-associated interactive metabolome of uropathogenic Escherichia coli and human urine

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Su, Qiao ^a   Guan, Tianbing ^a   Lv, Haitao ^a,b  

^a CHONGQING UNIVERSITY   (China)

^b Chinese National Human Genome Center at Shanghai   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SIDEROPHORE;

BIOSYNTHESIS; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; METABOLOME; NORMAL HUMAN; URINE; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

HEALTHY VOLUNTEERS; HOST-PATHOGEN INTERACTIONS; HUMANS; METABOLOME; SIDEROPHORES; URINE; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84964273805     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24099     Document Type: Article

References (53)

1. Flores-Mireles, A. L., Walker, J. N., Caparon, M. & Hultgren, S. J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13, 269-284 (2015).
2. Yan, L., Nie, W. & Lv, H. Metabolic phenotyping of the Yersinia high-pathogenicity island that regulates central carbon metabolism. Analyst 140, 3356-3361 (2015).
3. Lv, H., Hung, C. S., Chaturvedi, K. S., Hooton, T. M. & Henderson, J. P. Development of an integrated metabolomic profiling approach for infectious diseases research. Analyst 136, 4752-4763 (2011).
4. Henderson, J. P. et al. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLos Pathog. 5, e1000305 (2009).
5. Lv, H. & Henderson, J. P. Yersinia high pathogenicity island genes modify the Escherichia coli primary metabolome independently of siderophore production. J. Proteome Res. 10, 5547-5554 (2011).
6. Lv, H., Hung, C. S. & Henderson, J. P. Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli. J. Proteome Res. 13, 1397-1404 (2014).
7. Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113, 5-13 (2002).
8. Hannan, T. J. & Hunstad, D. A. A Murine Model for Escherichia coli Urinary Tract Infection. Methods Mol. Cell. Biol. 1333, 159 (2016).
9. Schroeder, A. R., Chang, P. W., Shen, M. W., Biondi, E. A. & Greenhow, T. L. Diagnostic Accuracy of the Urinalysis for Urinary Tract Infection in Infants < 3 Months of Age. Pediatrics, peds. 135, 965-971 (2015).
10. Shields-Cutler, R. R. et al. Human Urinary Composition Controls Siderocalin's Antibacterial Activity. J. Biol. Chem. 290, 15949-15960 (2015).
11. Greene, S. E., Hibbing, M. E., Janetka, J., Chen, S. L. & Hultgren, S. J. Human Urine Decreases Function and Expression of Type 1 Pili in Uropathogenic Escherichia coli. MBio 6, e00820 (2015).
12. Pluháček, T. et al. Characterization of microbial siderophores by mass spectrometry. Mass Spectrom Rev 35, 35-47 (2015).
13. Lv, H. Mass spectrometry-based metabolomics towards understanding of gene functions with a diversity of biological contexts. Mass Spectrom Rev 32, 118-128 (2013).
14. Cherkupally, P. et al. An efficient solid-phase strategy for total synthesis of naturally occurring amphiphilic marine siderophores: amphibactin-T and moanachelin ala-B. Org. Biomol. Chem. 13, 4760-4768 (2015).
15. Ruiz, J. A., Bernar, E. M. & Jung, K. Production of Siderophores Increases Resistance to Fusaric Acid in Pseudomonas protegens Pf-5. PLos One 10, e0117040 (2015).
16. Hider, R. C. & Kong, X. Chemistry and biology of siderophores. Nat Prod Rep 27, 637-657 (2010).
17. Sulochana, M. et al. Siderophore as a Potential Plant Growth-Promoting Agent Produced by Pseudomonas aeruginosa JAS-25. Appl. Biochem. Biotechnol. 174, 297-308 (2014).
18. Neilands, J. Siderophores: structure and function of microbial iron transport compounds. J. Biol. Chem. 270, 26723-26726 (1995).
19. Miethke, M. & Marahiel, M. A. Siderophore-based iron acquisition and pathogen control. Microbiol. Mol. Biol. Rev. 71, 413-451 (2007).
20. Watts, R. E. et al. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun. 80, 333-344 (2012).
21. Koh, E.-I. & Henderson, J. P. Microbial copper-binding siderophores at the host-pathogen interface. J. Biol. Chem. 290, 18967-18974 (2015).
22. Liu, Z. et al. Regulation of mammalian siderophore 2, 5-DHBA in the innate immune response to infection. J Exp Med 211, 1197-1213 (2014).
23. Madigan, C. A. et al. Lipidomic Analysis Links Mycobactin Synthase K to Iron Uptake and Virulence in M. tuberculosis. PLoS Pathog. 11, e1004792-e1004792 (2015).
24. Koh, E.-I. et al. Metal selectivity by the virulence-associated yersiniabactin metallophore system. Metallomics 7, 1011-1022 (2015).
25. Chaturvedi, K. S. et al. Cupric yersiniabactin is a virulence-associated superoxide dismutase mimic. ACS Chem. Biol. 9, 551-561 (2013).
26. Brumbaugh, A. R. et al. Blocking Yersiniabactin Import Attenuates Extraintestinal Pathogenic Escherichia coli in Cystitis and Pyelonephritis and Represents a Novel Target To Prevent Urinary Tract Infection. Infect. Immun. 83, 1443-1450 (2015).
27. Russo, T. A., Olson, R., MacDonald, U., Beanan, J. & Davidson, B. A. Aerobactin, but Not Yersiniabactin, Salmochelin, or Enterobactin, Enables the Growth/Survival of Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Ex Vivo and In Vivo. Infect. Immun. 83, 3325-3333 (2015).
28. Gao, Q. et al. Roles of iron acquisition systems in virulence of extraintestinal pathogenic Escherichia coli: salmochelin and aerobactin contribute more to virulence than heme in a chicken infection model. BMC Microbiol. 12, 143 (2012).
29. Valdebenito, M., Crumbliss, A. L., Winkelmann, G. & Hantke, K. Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int. J. Med. Microbiol. 296, 513-520 (2006).
30. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97, 6640-6645 (2000).
31. Beckonert, O. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2, 2692-2703 (2007).
32. Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. Metabo Analyst 3.0-making metabolomics more meaningful. Nucleic Acids Res. 43, W251-257 (2015).
33. Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D. & Wishart, D. S. Metabo Analyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40, W127-133 (2012).
34. Xia, J., Psychogios, N., Young, N. & Wishart, D. S. Metabo Analyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37, W652-660 (2009).
35. Wishart, D. S. et al. HMDB 3.0-the human metabolome database in 2013. Nucleic Acids Res. 41, D801-807 (2012).
36. Cui, Q. et al. Metabolite identification via the madison metabolomics consortium database. Nat. Biotechnol. 26, 162-164 (2008).
37. Chan, E. C. Y. et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 8, 352-361 (2008).
38. Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R. & Nicholson, J. K. Pharmacometabonomic identification of a significant hostmicrobiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. USA 106, 14728-14733 (2009).
39. Li, D. et al. Metabonomic Changes Associated with Atherosclerosis Progression for LDLR(-/-) Mice. J. Proteome Res. 14, 2237-2254 (2015).
40. Li, N., Song, Y. P., Tang, H. & Wang, Y. Recent developments in sample preparation and data pre-treatment in metabonomics research. Arch. Biochem. Biophys. 589, 4-9 (2015).
41. Rezzi, S. et al. Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res. 6, 4469-4477 (2007).
42. Wang, Y. et al. Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc. Natl. Acad. Sci. USA 105, 6127-6132 (2008).
43. Zhang, L. et al. Metabonomic analysis reveals efficient ameliorating effects of acupoint stimulations on the menopause-caused alterations in mammalian metabolism. Sci Rep 4, 3641 (2014).
44. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457-462 (2015).
45. Hryckowian, A. J., Baisa, G. A., Schwartz, K. J. & Welch, R. A. dsdA Does Not Affect Colonization of the Murine Urinary Tract by Escherichia coli CFT073. PLos One 10, e0138121 (2015).
46. Stærk, K., Khandige, S., Kolmos, H. J., Møller-Jensen, J. & Andersen, T. E. Uropathogenic Escherichia coli express type 1 fimbriae only in surface adherent populations under physiological growth conditions. J. Infect. Dis. 213, 386-394 (2015).
47. Sidaway, P. Infection: Exposure to human urine decreases type 1 pili expression in uropathogenic Escherichia coli. Nat. Rev. Urol. 12, 422-422 (2015).
48. King, J. E., Owaif, H. A. A., Jia, J. & Roberts, I. S. Phenotypic Heterogeneity in Expression of the K1 Polysaccharide Capsule of Uropathogenic Escherichia coli and its Down Regulation during Growth in Urine. Infect. Immun. IAI. 00188-00115 (2015).
49. Sabarly, V. et al. Interactions between genotype and environment drive the metabolic phenotype within Escherichia coli isolates. Environ. Microbiol. 1, 100-117 (2015).
50. Alteri, C. J., Smith, S. N. & Mobley, H. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLos Pathog. 5, e1000448 (2009).
51. Alteri, C. J., Himpsl, S. D. & Mobley, H. L. Preferential Use of Central Metabolism In Vivo Reveals a Nutritional Basis for Polymicrobial Infection. PLoS Pathog. 11, e1004601 (2015).
52. Hadjifrangiskou, M. et al. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol. Microbiol. 80, 1516-1529 (2011).
53. Korte-Berwanger, M. et al. Significance of the D-serine-deaminase and D-serine metabolism of Staphylococcus saprophyticus for virulence. Infect. Immun. 81, 4525-4533 (2013).